News Brief: Medline Soars in Record 2025 IPO Debut
Summary
Medline, a leading U.S. medical supplies manufacturer, made a stellar market debut on the Nasdaq, with shares surging over 22% following the largest global IPO of 2025. The offering raised $6.26 billion, marking a significant milestone for the IPO market.
Key Points
- Strong Debut: Shares opened at $35, a significant jump from the $29 IPO price, giving Medline a market value of at least $37 billion.
- Record Offering: The $6.26 billion raised makes it the largest U.S. listing since Rivian in 2021 and caps a strong year with over 200 IPOs.
- Private Equity Backing: The company is owned by a consortium of major PE firms (Blackstone, Carlyle, Hellman & Friedman) following a historic $34 billion buyout in 2021.
- Business Scale: Founded in 1966, Medline distributes ~335,000 products globally, with $25.5B in 2024 net sales and over 43,000 employees.
- Challenges & Competition: Faces headwinds from tariffs (expected $150-200M hit to 2026 pre-tax income) and competes with giants like McKesson and Cardinal Health.
新闻简报：Medline在2025年创纪录的IPO首日交易中大涨
摘要
美国领先的医疗用品制造商Medline在纳斯达克首日上市表现亮眼，股价飙升超过22%。此次IPO是2025年全球规模最大的上市活动，募集资金达62.6亿美元，标志着IPO市场的一个重要里程碑。
关键点
- 强势首秀：股票开盘报35美元，较29美元的发行价大幅上涨，使Medline市值至少达到370亿美元。
- 创纪录发行：62.6亿美元的募资额使其成为自2021年Rivian以来美国最大的上市案，为全年超过200宗IPO的强劲表现画上句号。
- 私募股权支持：公司由多家大型PE财团（黑石、凯雷、Hellman & Friedman）所有，这些机构在2021年以340亿美元完成了金融危机后最大的杠杆收购之一。
- 业务规模：公司成立于1966年，在全球分销约33.5万种产品，2024年净销售额达255亿美元，员工超过4.3万人。
- 挑战与竞争：面临关税不利影响（预计对2026财年税前利润造成1.5-2亿美元冲击），并与McKesson、Cardinal Health等巨头竞争。
Original Article Link: https://www.cnbc.com/2025/12/17/medline-debuts-nasdaq-biggest-ipo-2025.html